Ushanti Colour Chem Limited (NSE:UCL)

Achilles Therapeutics Revenue

In the fiscal year ending March 31, 2025, Ushanti Colour Chem had annual revenue of 780.50M INR with 53.92% growth. Ushanti Colour Chem had revenue of 411.29M in the half year ending March 31, 2025, with 142.05% growth.

• Revenue: 780.50M
• Revenue Growth: +53.92%
• P/S Ratio: 0.69
• Revenue / Employee: n/a
• Employees: 126
• Market Cap: 535.09M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2025	780.50M	273.40M	53.92%
Mar 31, 2024	507.10M	67.16M	15.27%
Mar 31, 2023	439.94M	-37.37M	-7.83%
Mar 31, 2022	477.30M	125.85M	35.81%
Mar 31, 2021	351.46M	-108.87M	-23.65%